A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/08 (2006.01) A61K 31/565 (2006.01) A61K 31/661 (2006.01) A61K 45/06 (2006.01) A61K 47/40 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2385065
A pharmaceutical formulation which comprises a parenterally acceptable carrier or diluent, estramustine phosphate and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables estramustine phosphate to be administered with no side effects at the site of injection.
La présente invention concerne des formulations pharmaceutiques qui comprennent un support ou un diluant convenant à la voie parentérale, un phosphate d'estramustine et un éther de cyclodextrine sulfoalkylée. On peut administrer cette formulation selon un traitement chimiothérapeutique combiné en association avec un ou plusieurs agents de chimiothérapie. Cette formulation permet d'administrer du phosphate d'estramutine sans effets secondaires au site d'injection.
Buzzi Giovanni
Colombo Paolo
Martini Alessandro
Muggetti Lorena
Pharmacia & Italia S.p.a.
Smart & Biggar
LandOfFree
Formulations for parenteral use of estramustine phosphate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations for parenteral use of estramustine phosphate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations for parenteral use of estramustine phosphate... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1863395